| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Rameshchandra Pandya Appointed as Director since September 2015 | Director | 18-Sep-2015 | Current |
Bhanuben Pravinbhai Vekariya Appointed as Director since May 2026 | Director | 19-May-2026 | Current |
Ghanshyam Parsottambhai Laheri Appointed as Director since March 2014 | Director | 31-Mar-2014 | Current |
Hetalben Dipakbhai Bhadiyadara Appointed as Director since June 2015 | Director | 12-Jun-2015 | Current |
Kishorkumar Maganbhai Kachhadiya Appointed as Director since June 2015 | Director | 12-Jun-2015 | Current |
Pareshkumar Ramjibhai Dhameliya Appointed as Director since August 2021 | Director | 04-Aug-2021 | Current |
Premium access Complete director detailsUnlock the complete director and KMP records available for Lupitas Pharmaceuticals Private Limited.
Verified entity values are shown only after access is granted. | |||
People Timeline
Explore the timeline of key personnel in Lupitas Pharmaceuticals Private Limited's leadership journey.
Loading...
Contact Details
- Address 33, Swaminarayan Nagar-1, Near Kalakunj, Varachha Road,, Surat Gujarat, 395006, India
- Telephone Upgrade
- Email Upgrade
- Pin Code 395006
- Country India
- Website lupitaspharmaceuticals.com
Frequently Asked Questions
You can contact Lupitas Pharmaceuticals Private Limited through their registered address at 33, Swaminarayan Nagar-1, Near Kalakunj, Varachha Road,, Surat Gujarat, 395006, India, or via their website at lupitaspharmaceuticals.com. Social media links are also provided where applicable.
The current directors of Lupitas Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
- GHANSHYAM PARSOTTAMBHAI LAHERI
- HETALBEN DIPAKBHAI BHADIYADARA
- KISHORKUMAR MAGANBHAI KACHHADIYA
- ASHISH RAMESHCHANDRA PANDYA
- PARESHKUMAR RAMJIBHAI DHAMELIYA
- Bhanuben Pravinbhai Vekariya
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.